SEBI Registration No. - INA000009515
helpdesk@researchicon.com

Blogs

Research Icon - Orient Paper's plant at Amlai commences operations;…

Orient Paper & Industries (Orient Paper) informed the exchanges that the company's paper plant at Amlai, Madhya Pradesh (MP) has commenced production from March 20, 2020. The plant was shut w.e.f. March 10, 2020, for the purpose of maintenance of…

Research Icon - Thyrocare Tech, Dr Lal Path Labs surge…

Healthcare stocks including Dr Lal Path Labs, and Thyrocare Technologies soared as much as 17.7 on the BSE on Monday, in an otherwise weak market, after the government allowed private laboritories to conduct blood tests for the coronavirus (Covid-19). According…

Research Icon - Rupee hits record low of 75.68 against…

The Indian rupee hit record low against the US dollar, weakening past the 76 per dollar mark for the first time. The local unit today opened at 75.69 amid a broad strengthening of the US dollar against other major currencies.…

Research Icon - Sensex, Nifty down 8%; All stocks in…

Equity benchmark indices opened in the sea of red on Monday amid global sell-off and a rise in coronavirus cases in India, also lockdown by the government, joining several countries in the fight against the deadly coronavirus (COVID-19) outbreak. It…

Research Icon - Ashoka Buildcon executes concession agreement with NHAI…

Further to the announcement made on February 13, 2020, regarding receipt of LoA, Ashoka Buildcon Limited informed that Ashoka Banwara Bettadahalli Road Private Limited (SPV) has executed a Concession Agreement with National Highways Authority of India (NHAI) on March 19,…

Research Icon - Nifty Pharma stocks outperform; IPCA Lab, Dr…

The Nifty Pharma index surged 3% at 6,839 levels in the morning trade as the rally was led by Cadila Healthcare, Dr Reddy’s, Sun Pharma and Cipla. According to the media statement that was published on Thursday, US President had…

We are not providing any guaranteed profit, profit Sharing Services, Demat handling, etc. Profit-loss is subject to market risk.